L17A/F19A Substitutions Augment the α-Helicity of β-Amyloid Peptide Discordant Segment

PLoS One. 2016 Apr 22;11(4):e0154327. doi: 10.1371/journal.pone.0154327. eCollection 2016.

Abstract

β-amyloid peptide (Aβ) aggregation has been thought to be associated with the pathogenesis of Alzheimer's disease. Recently, we showed that L17A/F19A substitutions may increase the structural stability of wild-type and Arctic-type Aβ40 and decrease the rates of structural conversion and fibril formation. However, the underlying mechanism for the increase of structural stability as a result of the alanine substitutions remained elusive. In this study, we apply nuclear magnetic resonance and circular dichroism spectroscopies to characterize the Aβ40 structure, demonstrating that L17A/F19A substitutions can augment the α-helicity of the residues located in the α/β-discordant segment (resides 15 to 23) of both wild-type and Arctic-type Aβ40. These results provide a structural basis to link the α-helicity of the α/β-discordant segment with the conformational conversion propensity of Aβ.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alanine / chemistry
  • Alzheimer Disease / metabolism*
  • Amyloid beta-Peptides / chemistry*
  • Circular Dichroism
  • Humans
  • Isotopes / chemistry
  • Magnetic Resonance Spectroscopy
  • Mutation
  • Protein Structure, Secondary

Substances

  • Amyloid beta-Peptides
  • Isotopes
  • Alanine

Grants and funding

This work was supported by grants from the National Science Council of the Republic of China (NSC99-2320-B-194-003-MY3, NSC101-2113-M-010-003-MY2 and MOST103-2113-M-010-002), Taipei Veterans General Hospital, Taiwan, ROC (V100C-180, V101C-003 and V102C-037) and a grant from Ministry of Education, Aiming for the Top University Plan.